Clinical trial
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination…
NCT00009737 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00009737 |
|---|---|
| Title | A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer |
| Official title | An Open-Label Randomized Phase III Study Comparing Xeloda (Capecitabine) With IV Bolus 5-Fluorouracil in Combination With Low-Dose Leucovorin as Adjuvant Chemotherapy in Patients Who Underwent Surgery for Dukes C Colon Cancer |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | 5-Fluorouracil, Leucovorin, Capecitabine [Xeloda] |
| Enrollment | 1,987 |
| Start date | Nov 1, 1998 |
| Primary completion | Apr 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Mar 17, 2004 |
| Last update posted | Jun 22, 2016 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Germany, Israel, Italy, Portugal, Spain, Switzerland and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: